Concept information
Terme préférentiel
Mercaptopurine
Type
-
mesh:Descriptor
Définition
- An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia.
Concept générique
Concepts spécifiques
Synonyme(s)
- 1,7-Dihydro-6H-purine-6-thione
- 50-44-2 (6-Mercaptopurine)
- 6112-76-1 (monohydrate)
- 6H-Purine-6-thione, 1,7-dihydro-
- 6-Mercaptopurine
- 6-Mercaptopurine Monohydrate
- 6-Thiohypoxanthine
- 6-Thiopurine
- E7WED276I5
- PKK6MUZ20G
Qualificatif(s) autorisé(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Action(s) pharmacologique(s)
Traductions
-
français
-
50-44-2 (6-Mercaptopurine)
-
6-Mercaptopurine
-
6112-76-1 (monohydrate)
-
E7WED276I5
-
PKK6MUZ20G
URI
http://data.loterre.fr/ark:/67375/JVR-KVKLF2PK-D
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}